Charming Medical Limited
MCTA
$29.36
$1.866.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.22M | 6.28M | 6.33M | 6.17M | 6.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.22M | 6.28M | 6.33M | 6.17M | 6.02M |
| Cost of Revenue | 201.60K | 200.50K | 199.40K | 184.90K | 170.40K |
| Gross Profit | 6.02M | 6.08M | 6.13M | 5.99M | 5.84M |
| SG&A Expenses | 4.16M | 4.31M | 4.47M | 4.38M | 4.28M |
| Depreciation & Amortization | 263.60K | 310.60K | 357.60K | 374.60K | 391.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.62M | 4.83M | 5.03M | 4.94M | 4.84M |
| Operating Income | 1.60M | 1.45M | 1.30M | 1.24M | 1.17M |
| Income Before Tax | 1.44M | 1.28M | 1.12M | 1.06M | 1.00M |
| Income Tax Expenses | 236.20K | 220.40K | 204.60K | 193.10K | 181.60K |
| Earnings from Continuing Operations | 1.20 | 1.06 | 0.91 | 0.87 | 0.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -20.30K | -40.60K | -42.20K | -43.80K |
| Net Income | 1.20M | 1.04M | 872.20K | 825.00K | 777.80K |
| EBIT | 1.60M | 1.45M | 1.30M | 1.24M | 1.17M |
| EBITDA | 1.86M | 1.76M | 1.66M | 1.61M | 1.56M |
| EPS Basic | 0.08 | 0.07 | 0.06 | 0.05 | 0.05 |
| Normalized Basic EPS | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 |
| EPS Diluted | 0.08 | 0.07 | 0.06 | 0.05 | 0.05 |
| Normalized Diluted EPS | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 |
| Average Basic Shares Outstanding | 61.35M | 61.35M | 61.35M | 61.35M | 61.35M |
| Average Diluted Shares Outstanding | 61.35M | 61.35M | 61.35M | 61.35M | 61.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |